Toshiyuki Shimizu

Cancer‐associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor‐β signaling

M. Yashiro, K. Hirakawa, Tatsunari Fukuoka, 2014, International journal of cancer.

Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling

T. Sawada, M. Yashiro, K. Hirakawa, 2013, PloS one.

A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.

M. Yashiro, K. Hirakawa, M. Tendo, 2006, Gastroenterology.

Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line

K. Miyazono, Y. Ishikawa, T. Imamura, 2007, Cancer science.

An inhibitor of transforming growth factor beta type I receptor ameliorates muscle atrophy in a mouse model of caveolin 3-deficient muscular dystrophy

K. Tsuchida, Y. Sunada, S. Noji, 2012, Laboratory Investigation.

Combination effect of a TGF‐β receptor kinase inhibitor with 5‐FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice

M. Yashiro, K. Hirakawa, H. Kawajiri, 2010, Cancer science.

A novel Toll-like receptor 7/8-specific antagonist E6742 Ameliorates clinically relevant disease parameters in murine models of lupus.

S. Ishizaka, Qian Chen, Toshiyuki Shimizu, 2023, European journal of pharmacology.

Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells

T. Shimizu, M. Yashiro, H. Kawajiri, 2010, British Journal of Cancer.